Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Retargeted adenovirus vector active in preclinical cancer models

Dec. 10, 2008

Ad5-CMV-NIS gene therapy enters dose-finding phase I study for prostate cancer

Dec. 10, 2008

Azacitidine investigated in AML, MDS after hematopoietic stem cell transplantation

Dec. 9, 2008

Pilot study shows potential of ON-1910Na in myelodysplastic syndromes

Dec. 9, 2008

Silence Therapeutics to submit CTA for Atu-027 in December 2008

Dec. 9, 2008

FDA grants orphan drug designation to Genta's tesetaxel for advanced melanoma

Dec. 9, 2008

PharmaMar submits registration dossier to EMEA for Yondelis in relapsed ovarian cancer

Dec. 9, 2008

VentiRx commences phase I VTX-2337 trial in cancer

Dec. 5, 2008

Yakult initiates clinical study of Campto for pancreatic cancer

Dec. 5, 2008

OncoGenex reports positive results from phase II clinical trial of OGX-011 in prostate cancer

Dec. 5, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...